期刊文献+

聚山梨酯80的脂肪酸组成及其精制方法研究 被引量:10

Study on Fatty Acids Composition and Refining Methods of Polysorbate 80
下载PDF
导出
摘要 目的:以聚山梨酯80的色泽与脂肪酸组成作为考察指标,探求可提高其品质的有效途径。方法:参考《欧洲药典》建立聚山梨酯80脂肪酸组成的检测方法并对市售样品进行测定,后围绕浊点萃取法、三相分离法以及基于其制备原料(油酸)纯度控制这3种方法展开聚山梨酯80的精制工艺研究。结果:当选用高纯度油酸作为聚山梨酯80制备的起始原料时,产品的脂肪酸组成可达到《欧洲药典》要求,并且聚山梨酯80经浊点萃取法和三相分离法两种方法精制后,尤其经三相分离法精制后,产品的色泽可接近无色。结论:应当选用高品质起始原料进行聚山梨酯80的制备,并配合三相分离法的使用,可实现聚山梨酯80产品外观与内在品质的共同提高。 Objective: To improve the quality of polysorbate 80 by monitoring its color and fatty acid. Methods: This paper established a method to detect the fatty acids composition of polysorbate 80 with reference to the European Pharmacopoeia and used this method to detect the polysorbate 80 from markets.,.Based on the cloud point extraction, three phase partitioning and purification control of the starting material (oleic acid), we studied the refining technology of polysorbate 80. Results: The outcomes demonstrate that if oleic acid with high quality was used as raw material, the fatty acid composition of / polysorbate 80 will meet the standard of European Pharmacopoeia. Besides, after being refined with the two methods, especially with three phase partitioning, the quality of polysorbate 80 will get further improved through making the products nearly colorless. Conclusion: Utilizing three phase partitioning accompanied with high-quality starting materials, the outlook and quality of the products were both improved.
出处 《药学与临床研究》 2010年第1期46-49,共4页 Pharmaceutical and Clinical Research
关键词 聚山梨酯80 脂肪酸组成 精制 浊点萃取法 三相分离法 olysorbate 80 Fatty acids composition Refining Cloud point extraction Three phase partitioning
  • 相关文献

参考文献7

  • 1吴毅,金少鸿.药用辅料吐温80的药理、药动学及分析方法研究进展[J].中国药事,2008,22(8):717-720. 被引量:89
  • 2European directorate for the quality of medicines. European Pharmacopoeia[S]. 6th, Germany, 2008: 2711-2. 被引量:1
  • 3戚文斌,浦炳寅.表面活性剂与分析化学(下)[M].北京:中国计量出版社,1987. 被引量:1
  • 4Stubenrauch C, Schlarmann J, Sottmann T, et al. Purification of nonionic alkyl polyglycolether (CiEj) surfactants: the "inverse" 3PHEX technique [J ]. J Colloid InteoCace Sci, 2001, 244(2): 447-9. 被引量:1
  • 5Schubert KV, Strey R, Kahlweit M. 3PHEX: a new surfactant purification technique Trends in colloid and interface science V. Progress in Colloid and Polymer Science [M]. Heidelberg: Springer Berlin, 1991, 84:103-6. 被引量:1
  • 6Schubert KV, Strey R, Kahlweit M. A new purification technique for alkyl polyglycol ethers and miscibility gaps for water CiEj [J]. J Colloid Interface Sci, 1991, 141(1): 21-9. 被引量:1
  • 7张金花,唐季安.表面活性剂的提纯与鉴定[J].化学通报,1999(4):7-13. 被引量:12

二级参考文献34

  • 1何永亮,易勇,王红星,闫志锋.含吐温-80中药注射液对犬致过敏的研究[J].中药药理与临床,2005,21(1):55-56. 被引量:44
  • 2北原文雄 早野茂夫 等.表面活性剂分析和试验法[M].北京:轻工业出版社,1988.253-303. 被引量:11
  • 3Tang Fangqiong,J Colloid Interface Sci,1989年,131卷,2期,498页 被引量:1
  • 4北原文雄,表面活性剂分析和试验方法,1988年,61页 被引量:1
  • 5戚文彬,表面活性剂与分析化学.下,1987年 被引量:1
  • 6赵前 章建民 孙小力.吐温80的药理作用[J].中药通报,1989,11(8):502-503. 被引量:2
  • 7Siderov J, Prasad P, De Boer R, et al. Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide [J]. BrJ Canee, 2002, 86: 12. 被引量:1
  • 8Van Tellingen O, Beijnen J H, Verweij J, et al. Rapid esterasesensitive breakdown of polysorbate 80 and its impact on the plasma phal. maeokineties of doeetaxel and metabolites in mice [J]. Clin Cancer Res, 1999, 5 (10): 2918. 被引量:1
  • 9Eschalier A, I.avarenne J, Burtin C, et al. Study of histamine release induced by acute administration of antitumor agents in dogs [J]. Cancer Chem Pharmacol, 1988, 21: 246. 被引量:1
  • 10Freilich R J, Balmaceda C, Seid - nanA D. el al. Motor neuropathy due to doeetaxel and paclitaxel [J]. Neurology, 1996, 47: 115. 被引量:1

共引文献99

同被引文献115

引证文献10

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部